Iliac Stent Market Size is Expected to be USD 2.3 Billion in by 2034; Rising Technological Advancements to Aid Market Expansion

Download Sample

Published Date: March 2025

Iliac stent market refers to the medical devices used in treatment of diseases related to the iliac arteries. Iliac stents are small, mesh-like devices typically made of metal (such as stainless steel or nitinol) which are inserted into the iliac arteries to keep them open and restore proper blood flow. Continuous advancements in stent technology, such as the development of drug-eluting stents (DES) and bioabsorbable stents, enhance the efficacy of treatment and improve patient outcomes.

Iliac Stent Market Segmentation Analysis:

By Type	Self-Expandable Stents, Balloon-Expandable Stents, and Covered Stents
By Artery Lesions	Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions
By Material	Stainless Steel, Nickel-Titanium (Nitinol), and Cobalt-Chromium
By End-User	Hospitals, Outpatient facilities, and Others

Iliac Stent Market??????? Report Highlights:

Iliac stent market size accounted for USD 1.3 Billion in 2024.
The market is look forward to grow at USD 2.3 Billion by 2034 and is expected to grow at a CAGR of 6.1% during the forecast period.
Based on type, self-expandable stents segment dominates in target market growth.
On the basis of artery lesions, common iliac artery lesions hold the largest share in target market.
Stainless steel segment has the largest market share in the market, into material way.
Accordance to end user, Hospitals segment is the most dominant segment in the market.
North America region holds the largest market share.

Iliac Stent Market Dynamics:

Growing Factor	Challenge Factor	Market Trend
Growing Healthcare Awareness and Diagnosis	High Cost of Treatment	Advancements in Drug-Eluting Stents

Iliac Stent Market Key Highlights

In May 2024, the one-year BIONETIC-I study showed that treating the iliac artery with BIOTRONIK's Dynetic-35 Cobalt Chromium Balloon-Expandable Stent System is safe and effective. New findings reported at LINC 2024 support using thin-strut cobalt chromium stents in calcified iliac lesions. The BIONETIC-I results show that the Dynetic-35 stent is safe and efficacious in highly calcified lesions, which is critical when treating iliac arteries.

Iliac Stent Market Report Analysis:

New Product Launch:

·In January 2025, Bentley launched BeFlow iliac covered stent system at the Leipzig Interventional Course (LNC). It was designed for the treatment of iliac occlusive and stenotic diseases and enables physicians to treat patients suffering from arteriosclerosis with a covered stent. It is aimed to deliver safe treatment, long-term patency and durability of iliac stent.

·In June 2024, Philips launched the Duo Venous Stent System to treat symptomatic venous outflow blockage. Following FDA premarket approval, the Sanger Heart & Vascular Institute at Atrium Health treated the first patient with the innovative implantable medical device. The Duo Venous Stent System, designed for the unique demands of venous architecture and blockages, consists of two stents of varying sizes: Duo Hybrid and Duo Extend.

Browse ∼40 market data tables and ∼35 figures through ∼160 slides and in-depth TOC on “Iliac stent Market, By Type (Self-Expandable Stents, Balloon-Expandable Stents, Covered Stents), Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions), Material (Stainless Steel, Nickel-Titanium (Nitinol), and Cobalt-Chromium), End-User (Hospitals, Outpatient facilities, and Others), and Region - Trends, Analysis, and Forecast till 2034”

For more insights into the Iliac stentMarket and its future trends, visit the link: https://www.prophecymarketinsights.com/market_insight/iliac-stent-market-5535

Competitive Landscape of Iliac stent Market:

The key players operating in the Iliac stent market are Abbott Laboratories, Alvimedica, B. Braun SE, Becton, Dickinson and Company, Biotronik SE & Co KG, Boston Scientific Corporation, Cook Medical, Getinge AB, iVascular, Medtronic Plc, Terumo Corporation, and W. L. Gore & Associates.